Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

MonoGen closes equity capital bought deal private placement financing for an aggregate amount of US$7.5 million

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

GMP Securities

On April 16, 2008, MonoGen, Inc. announced that it had closed on the previously announced equity capital bought deal private placement financing for an aggregate amount of $7.5 million, including the exercise of the underwriter's over-allotment option. GMP Securities L.P. was the underwriter for this financing. MonoGen, Inc., headquartered in the Chicago area, is a medical device and diagnostics company providing high-quality and cost-effective cytological screening and diagnostic products to healthcare providers in the anatomic pathology industry. GMP Securities was advised by a team from Fasken Martineau that included Rubin Rapuch, Georges Dubé and Karoline Kralka.

Team

    Subscribe

    Receive email updates from our team

    Subscribe